Article

MicroRNAs immune response profile to COVID-19 vaccine boost in cancer patients under active treatment

2026-04-21

Abstract excerpt

<title>Abstract</title> <p>Cancer patients are at increased risk of severe COVID-19 outcomes. Understanding their immunological response to SARS-CoV-2 mRNA vaccination is essential for identifying molecular biomarkers that can predict vaccine efficacy. MiRNAs are promising biomarkers because they regulate immunity-related genes through virus-host interactions. This study aims to validate a specific miRNA profile...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 88df6012-93fc-5f9e-84bd-5c95dae81568
DOI: 10.21203/rs.3.rs-9169442/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

MicroRNAs immune response profile to COVID-19 vaccine boost in cancer patients under active treatmentDOI 10.21203/rs.3.rs-9169442/v1Read

MicroRNAs are enriched at COVID-19 genomic risk regions, and their blood levels correlate with the COVID-19 prognosis of cancer patients infected by SARS-CoV-2Semantic proximity Read

COVID-19–Sensitive Tumour Response – 2-Year Assessment of the SARS-CoV-2 Humoral Response in Cancer Patients in Oncology Hospital in PolandSemantic proximity Read

Predictive model for BNT162b2 vaccine response in cancer patients based on cytokines and growth factorsSemantic proximity Read

Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelinesSemantic proximity Read

Impaired immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CAR T-cell therapySemantic proximity Read

COVID-19 Vaccines: Bolstering Cancer TreatmentSemantic proximity Read

Efficacy and longevity of immune response to 3 <sup>rd</sup> COVID-19 vaccine and effectiveness of a 4 <sup>th</sup> dose in severely immunocompromised patients with cancerSemantic proximity Read

Immunogenicity of SARS-CoV-2 mRNA Vaccines in Patients with Cancer: Findings from an International Collaborative Cohort StudySemantic proximity Read

COVID-19 and Malignancy: Exploration of the possible genetic and epigenetic interlinks and overview of the vaccination scenario.Semantic proximity Read

Longitudinal Vaccine-Induced Humoral Immune Response in Cancer PatientsSemantic proximity Read

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE studySemantic proximity Read

CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancerSemantic proximity Read